How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring?
Ajjan RA
Diabetes Technology & Therapeutics. 2017:19(S2):S27-36.
Leggi
Breaking news
Clinical Use of Continuous Glucose Monitoring in Adults with Type 2 Diabetes
Carlson AL, Mullen DM and Bergenstal RM
Diabetes Technology & Therapeutics. 2017:19(S2):S4-11.
Leggi
Flash Glucose Monitoring: The Future Is Here
Garg SK, Akturk HK
Diabetes Technology & Therapeutics. 2017:19(S2):S1-3
Leggi
Impact of the Metabolic Syndrome on Mortality is Modified by Objective Short Sleep Duration
Fernandez-Mendoza J, He F, LaGrotte C,et al.
J Am Heart Assoc. Pub. online May 17, 2017
Leggi
Merits of Invasive Strategy in Diabetic Patients with Non-ST Elevation Acute Coronary Syndrome
Jneid H
J Am Heart Assoc. Pub. online May 20, 2017
Leggi
Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study
Kosiborod M, Cavender MA, Fu aZ, et al.
Circulation. Pub. online May 18, 2017
Leggi
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on 24-Hour Ambulatory Blood Pressure: A Systematic Review and Meta-Analysis
Baker WL, Buckley LF, Kelly MS, et al.
J Am Heart Assoc. Pub. online May 18, 2017
Leggi
Early Invasive Strategy and In-Hospital Survival Among Diabetics with Non-ST-Elevation Acute Coronary Syndromes: A Contemporary National Insight
Mahmoud AN, Elgendy IY, Mansoor H,et al.
J Am Heart Assoc. 2017;6:e005369
Leggi
EMPA-REG OUTCOME: The Nephrologist’s Point of View
Wanner C
Am J Med. Pub. online May 16, 2017
Leggi
Evidence for Two Distinct Phenotypes of Chronic Kidney Disease in Individuals with Type 1 Diabetes Mellitus
Penno G, Russo E, Garofolo M, et al.
Diabetologia 2017;60(6):1102-13
Leggi